Anhídrido propiónico, mínimo 98,5 %, para síntesis, 500 ml, envase de vidrio

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide, 95%, 1g

(5-Methoxy-1H-benzoimidazol-2-yl)-methanol, 95.0%, 1g

4-(Boc-amino)-1-butanol, 95.0%, 1g

(2S,3R,4R,5R,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate, 98.0%, 25g

2-Bromophenylboronic Acid (contains varying amounts of Anhydride)5g

Hexyl 2-chloroisonicotinate, 97.0%, 1g

4-chloro-2-(1,1-difluoroethyl)pyrimidine, 97, 100mg

(R)-1-(5-Methyl-1,2,4-oxadiazol-3-yl)ethan-1-amine hydrochloride, 98%, 100mg

1-(2,4-Dimethylphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 95.0%, 500mg

(2-((2-Isopropyl-5-methylphenoxy)methyl)phenyl)boronic acid, 98%, 5g

Ethyl 2-hydroxy-4-(trifluoromethyl)pyrimidine-5-carboxylate hydrate, 95.0%, 5g

1-methyl-3-(pyrazin-2-yl)-1H-pyrazole-5-carboxamide, 95.0%, 500mg